[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 30, 2007, Pages 12462-12467

  Prasanphanich, Adam F ^a,c   Nanda, Prasant K ^a   Rold, Tammy L ^a   Ma, Lixin ^a,b,c   Lewis, Michael R ^c,d   Garrison, Jered C ^a,c   Hoffman, Timothy J ^a,c   Sieckman, Gary L ^c   Figueroa, Said D ^a,c   Smith, Charles J ^a,b,c  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

Bombesin; Copper 64; Molecular imaging; PC 3 tumors

Indexed keywords

1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID 8 AMINOOCTANOIC ACID BOMBESIN[7-14]AMIDE CU 64; GASTRIN RELEASING PEPTIDE RECEPTOR; RADIOISOTOPE; UNCLASSIFIED DRUG; 64CU 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID 8 AMINOOCTANOIC ACID BOMBESIN(7 14)AMIDE; 64CU-1,4,7-TRIAZACYCLONONANE-1,4,7-TRIACETIC ACID-8-AMINOOCTANOIC ACID-BOMBESIN(7-14)AMIDE; BOMBESIN RECEPTOR; BORON DERIVATIVE; DIAGNOSTIC AGENT; METHACRYLIC ACID DERIVATIVE; METHACRYLIC ACID METHYL ESTER; PEPTIDE FRAGMENT; SINGLE HETEROCYCLIC RINGS; SUPER BOND; SUPER-BOND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER MODEL; CONJUGATE; DISSOCIATION; DRUG ACCUMULATION; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; DRUG TUMOR LEVEL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; IN VIVO STUDY; LUNG CANCER; MOUSE; NONHUMAN; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; RADIOACTIVITY; URINARY EXCRETION; ANIMAL; ANTIBODY SPECIFICITY; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOUSE MUTANT; NEOPLASM; TUMOR CELL LINE;

ANIMALS; BORON COMPOUNDS; CELL LINE, TUMOR; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; METHACRYLATES; METHYLMETHACRYLATES; MICE; MICE, SCID; MOLECULAR STRUCTURE; NEOPLASMS; ORGAN SPECIFICITY; PEPTIDE FRAGMENTS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, BOMBESIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 34547630542     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0705347104     Document Type: Article

References (43)

1. Kwekkeboom D, Krenning EP, de Jong M (2004) J Nucl Med 41:1704-1713.
2. Krenning EP, de Jong M (2000) Ann Oncol 11:267-271.
3. Blum JE, Handmaker H (2002) Curr Pharm Des 8:1815-1826.
4. Blum J, Handmaker H, Rinne NA (2002) Curr Pharm Des 8:1827-1836.
5. Behr TM, Gotthardt M, Barth A, Behe M (2001) Q J Nucl Med 45:189-200.
6. Signore A, Annovazzi A, Chianelli M, Corsetti F, Van de Wiele C, Waterhourse R, Scopinaro F (2001) Eur J Nucl Med 28:1555-1565.
7. Okarvi SM (2001) Eur J Nucl Med 28:929-938.
8. Liu S, Edwards DS (1999) Chem Rev 99:2235-2268.
9. Blok D, Feitsma RIJ, Vermeij P, Pauwels EJK (1999) Eur J Nucl Med 26:1511-1519.
10. Goodwin DA, Meares CF (1999) Cancer Biother Radiopharm 14:145-152.
11. Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WAP, Kooij PPM, Oei HY, Hagen M, Postema PTE, Jong M, Reubi JC, et al. (1993) Eur J Nucl Med 20:716-731.
12. Smith CJ, Volkert WA, Hoffman TJ (2005) Nucl Med Biol 32:733-740.
13. Smith CJ, Volkert WA, Hoffman TJ (2003) Nucl Med Biol 30:861-868.
14. Markwalder R, Reubi JC (1999) Cancer Res 59:1152-1159.
15. Pinski J, Halmos G, Yano T, Szepeshazi K, Qin Y, Ertl T, Schally AV (1994) Int J Cancer 57:574-580.
16. Sun B, Schally AV, Halmos G (2000) Regul Pept 90:77-84.
17. American Cancer Society (2007) Cancer Facts and Figures (Am Cancer Soc, Atlanta, GA).
18. Carducci MA, DeWeese TL, Nelson WG, Simons JW, Sinibaldi V, Eisenberger MA (1996) Semin Oncol 23:56-62.
19. Newling DW (1997) Urol Res 25:S73-S78.
20. Tang DG, Porter AT (1997) Prostate 32:284-293.
21. Anderson CJ, Welch MJ (1999) Chem Rev 99:2219-2234.
22. Rogers BE, Manna DD, Safavy A (2004) Cancer Biother Radiopharm 19:25-34.
23. Rogers BE, Bigott HM, McCarthy DW, Delia Manna D, Kim J, Sharp TL, Welch MJ (2003) Bioconjugate Chem 14:756-763.
24. Chen X, Park R, Hou Y, Tohme M, Shahinian AH, Bading JR, Conti PS (2004) J Nucl Med 45:1390-1397.
25. Yang Y-S, Zhang X, Xiong Z, Chen X (2006) Nucl Med Biol 33:371-380.
26. Bass LA, Wang M, Welch MJ, Anderson CJ (2000) Bioconjugate Chem 11:527-532.
27. Sprague JE, Peng Y, Sun X, Weisman GR, Wong EH, Achilefu S, Anderson CJ (2004) Clin Cancer Res 10:8674-8682.
28. Boswell CA, Sun X, Niu W, Weisman GR, Wong EH, Rheingold AL, Anderson CJ (2004) J Med Chem 47:1465-1474.
29. Sun X, Wuest M, Weisman GR, Wong EH, Reed DP, Boswell CA, Motekaitis R, Martell AE, Welch MJ, Anderson CJ (2002) J Med Chem 45:469-477.
30. Kukis DL, Li M, Meares CF (1993) Inorg Chem 32:3981-3982.
31. Kukis DL, Diril H, Greiner DP, DeNardo SJ, DeNardo GL, Salako QA, Meares CF (1994) Cancer 73(Suppl):779-786.
32. Wieghardt K, Bossek U, Chaudhuri P, Herrmann W, Menke BC, Weiss J (1982) Inorg Chem 21:4308-4314.
33. Delgado R, Sun Y, Motekaitis RJ, Martell AE (1993) Inorg Chem 32:3320-3326.
34. Smith CJ, Gali H, Sieckman GL, Hayes DL, Owen NK, Mazuru DG, Volkert WA, Hoffman TJ (2003) Nucl Med Biol 30:101-109.
35. Hoffman TJ, Gali H, Smith CJ, Sieckman GL, Hayes DL, Owen NK, Volkert WA (2003) J Nucl Med 44:823-831.
36. Smith CJ, Gali H, Sieckman GL, Higginbotham C, Volkert WA, Hoffman TJ (2003) Bioconjugate Chem 14:93-102.
37. Maina TM, Nock BA, Zhang H, Nikolopoulou A, Waser B, Reubi J-C (2005) J Nucl Med 46:823-830.
38. Garrison JC, Rold TL, Sieckman GL, Figueroa SD, Volkert WA, Jurisson SS, Hoffman TJ (2007) J Nucl Med, in press.
39. Kelloff GJ, Hoffman JM, Johnson B, Scher HI, Siegel BA, Cheng EY, Cheson BD, O'Shaughnessy J, Guyton KZ, Mankoff DA, et al. (2005) Clin Cancer Res 11:2785-2808.
40. Kumar R, Zhuang H, Alavi A (2004) Radiol Clin North Am 42:1141-1153.
41. Hofer C, Laubenbacher C, Block T, Breul J, Hartung R, Schwaiger M (1999) Eur Urol 36:31-35.
42. Sung J, Espiritu JI, Segall GM, Terris MK (2003) BJU Int 92:24-27.
43. Jana S, Blaufox MD (2006) Semin Nucl Med 36:51-72.